Aventis Behring Gmbh

Csl Behring Gmbh

Zlb Behring Gmbh

Peter Gronski

Gerhard Dickneite

Hubert Metzner

J&uuml;rgen R&ouml;misch

Stephen Poole

Harald Stauss

Bernhard Vohwinkel

Pauline Sxouter

Elaine Gray

Bernd Hoppe

Monika Kroez

Peter Zipfel

Christine Skerka

Christoph Licht

The invention relates to the use of Factor H for the manufacture of a medicament to treat both chronic nephropathies which are not causally associated with proteinuria and chronic nephropathies which are causally associated with proteinuria. The invention also relates to large scale purification methods for Factor H.

Factor H for the treatment of chronic nephropathies and production thereof

The use of a tissue glue comprising a stabilized fibrinogen preparation, which can be stored in the liquid or frozen state and comprises a chaotropic substance, and a thrombin preparation, for reducing or preventing tissue adhesions, is described.

Tissue glue with improved antiadhesive properties

A pharmaceutical preparation is described while is useful for the treatment of inflammatory processes being accompanied by an increased distribution of cytokines and/or tissue factor in the human body, which preparation contains Antithrombin III as active ingredient.

Pharmaceutical preparation for the treatment of inflammatory processes

Stabilized protein preparations for a tissue adhesive

Growing community of inventors

Marburg, Germany

Peter Gronski